Skip to content

NEUROONE MEDICAL TECHNOLOGIES Corp

NMTC · XNAS

CIK 1500198fmd_0QHRC656H49BRWKXNQB7H7FHPCManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2010 to Jun 30, 2026, 65 periods

Income Statement · Annual · Millions · USD
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues00–––00239
Cost of revenue–––––00124
Net interest income–––(0)(8)(0)––––
Gross profit–––––(0)(0)015
Research and development–––2245755
Selling, general and administrative–––––67787
Total operating expenses00–671012141312
Operating income(0)(0)–(6)(5)(10)(10)(12)(12)(4)
Interest expense0–0––0––––
Other non-operating income (expense)––––––000–
Income before taxes(0)(0)––(2)–(10)(12)(12)(4)
Income tax expense00–––(0)––––
Net income from continuing operations(0)(0)––––––––
Net income(0)(0)–(7)(14)(10)(10)(12)(12)(4)
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) financial statements · FinancialMD